{
    "2021-07-16": [
        [
            {
                "time": "",
                "original_text": "扬子江猛攻150亿造影剂市场 集采低价拿下9省市",
                "features": {
                    "keywords": [
                        "扬子江",
                        "造影剂",
                        "集采",
                        "低价",
                        "市场"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药(600276)：SHR3680片III期撞线 前列腺癌系统性产品推进",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "SHR3680",
                        "III期",
                        "前列腺癌",
                        "产品推进"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "每日“药”闻|药明康德、康龙化成年中利润大增；恒瑞医药AR抑制剂三期临床成功",
                "features": {
                    "keywords": [
                        "药明康德",
                        "康龙化成",
                        "利润大增",
                        "恒瑞医药",
                        "AR抑制剂",
                        "三期临床"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药：瑞马唑仑公告撰写无误",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "瑞马唑仑",
                        "公告",
                        "无误"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药：公司目前未有赴港上市的计划",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "赴港上市",
                        "计划"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2023-07-15",
                "original_text": "A股融资融券日报：两融余额增加9.91亿元（7月15日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额",
                        "增加"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}